Definitive Contract 75F40121C00179

Award Date 9/26/21
Potential Completion Date 6/28/24
Potential Value $900K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $811,680.97 firm-fixed price contract to the Research Triangle Institute (RTI International), a non-profit research organization, to provide services supporting a study titled "Incorporating Women's Experiences and Prioritization of Treatment Outcomes into Regulatory Decision-Making for Medical Products." The contract has an ultimate completion date of September 30, 2026. This contract award was not set aside for a specific business...
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute on Drug Abuse, to Research Triangle Institute (RTI) International. The contract is for $1,205,948.00 and requires RTI to complete tasks related to the acquisition, analysis, storage, and shipment of bulk drugs, other chemical compounds, and drug dosage forms. This work falls under the major program of "Preparation and Distribution of...
This is a $951,611.00 firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International), an independent non-profit research organization. The contract, which does not have a set-aside designation, is for lab analysis services in support of the FDA's mission. RTI International, which has a range of federal contract and grant vehicles, will leverage its expertise across disciplines such as health, environment, and policy...
This is a federal contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Research Triangle Institute (RTI) International, a nonprofit research organization. The contract is for the Preparation and Distribution of Research Drug Products and has a potential value of $1,393,058.00. The contract is a Cost Plus Fixed Fee Delivery Order that runs from September 20, 2019 to September 19, 2024. The place of...
The Department of Health and Human Services' Food and Drug Administration awarded a $306,099 firm fixed price blanket purchase agreement call contract to Research Triangle Institute - doing business as RTI International. The contract is placed against RTI's existing Multiple Award Schedule contract vehicle to add contract line items numbers to an existing requirement with no financial impact. RTI will perform the work at its Research Triangle Park, North Carolina location from September 2021...
This is a federal contract award to Research Triangle Institute (RTI International), a prominent non-profit research organization, by the Food and Drug Administration (FDA), a civilian agency. The contract, valued at $2,054,480.86, is for the "CAMPAIGN EVALUATION DATA HARMONIZATION PROJECT" and has a period of performance through August 28, 2029. The contract is a delivery order using a time and materials pricing type. RTI International has significant experience supporting federal...
This is a federal contract award from the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International), an independent non-profit research organization. The $1,288,593.00 contract is a Delivery Order under a Time and Materials contract for "CTP OHCE PROMISING THEMES STUDIES" and has an ultimate completion date of April 8, 2025. There is no set-aside designation for this award. RTI International has a strong track record of competitively winning federal...
Research Triangle Institute (RTI) International was awarded a firm fixed price task order worth $252,624.96 by the Department of Health and Human Services' Food and Drug Administration (FDA) under the agency's Quick Turnaround Social Science Research Services blanket purchase agreement (BPA). The task order, entitled "Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites," requests research and analysis to inform FDA programs and policies regarding...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to Research Triangle Institute (RTI International), a non-profit research organization. The contract is for the "Preparation and Distribution of Research Drug Products" and has a period of performance from March 20, 2025 to March 19, 2029, with a ceiling value of $1,497,865.00. The contract type is Delivery Order with a Cost Plus Fixed Fee pricing structure. The contract does not...
This is a firm fixed-price task order awarded by the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International), a non-profit research organization, to acquire communicating scientific information about unapproved uses of FDA-approved medical products. The task order is part of a larger Multiple Award Schedule (MAS) contract and has a ceiling value of $715,402.00 with a completion date of September 6, 2027. The contract does not have a set-aside designation. RTI...

This is a Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International) for a project titled "ASSESSING WHETHER DRUG DISCRIMINATION SELECTIVELY EVALUATES PHARMACOLOGICAL MECHANISMS OF ACTION". The $899,795.00 contract has a completion date of June 28, 2024. RTI International is an independent, non-profit research organization that provides a wide range of technical and advisory services to the federal government. The contract is not associated with a larger vehicle and does not have a set-aside designation. Based on the FDA's mission, this contract likely supports research and evaluation related to the pharmacological mechanisms of drug discrimination, which is an important consideration for the agency's oversight of drug development and safety.

Generated 9/10/24, 10:24 AM